These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 32547241)

  • 1. Increasing Incidence and Prevalence of Acquired Hemolytic Anemias in Denmark, 1980-2016.
    Hansen DL; Möller S; Andersen K; Gaist D; Frederiksen H
    Clin Epidemiol; 2020; 12():497-508. PubMed ID: 32547241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small Paroxysmal Nocturnal Hemoglobinuria Clones in Autoimmune Hemolytic Anemia: Clinical Implications and Different Cytokine Patterns in Positive and Negative Patients.
    Fattizzo B; Giannotta J; Zaninoni A; Kulasekararaj A; Cro L; Barcellini W
    Front Immunol; 2020; 11():1006. PubMed ID: 32582157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reappraisal of the etiology of extracorpuscular non-autoimmune acquired hemolytic anemia in 2657 hospitalized patients with non-neoplastic disease.
    Kok VC; Lee CK; Horng JT; Lin CC; Sung FC
    Clin Med Insights Pathol; 2014; 7():11-4. PubMed ID: 24808725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of hemolytic characteristics among paroxysmal nocturnal hemoglobinuria, autoimmune hemolytic anemia and hereditary spherocytosis].
    Li WW; Shi J; Huang ZD; Nie N; Shao YQ; Li XX; Ge ML; Zhang J; Huang JB; Jin P; Wang M; Zheng YZ
    Zhonghua Xue Ye Xue Za Zhi; 2018 Apr; 39(4):299-304. PubMed ID: 29779325
    [No Abstract]   [Full Text] [Related]  

  • 5. [Aquired immune hemolytic anemias].
    Salama A
    Ther Umsch; 2004 Feb; 61(2):178-86. PubMed ID: 15018403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement Mediated Hemolytic Anemias in the COVID-19 Era: Case Series and Review of the Literature.
    Fattizzo B; Pasquale R; Bellani V; Barcellini W; Kulasekararaj AG
    Front Immunol; 2021; 12():791429. PubMed ID: 34899761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel insights into the treatment of complement-mediated hemolytic anemias.
    Berentsen S; Hill A; Hill QA; Tvedt THA; Michel M
    Ther Adv Hematol; 2019; 10():2040620719873321. PubMed ID: 31523413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Case of Paroxysmal Cold Hemoglobinuria Possessing Moderate Paroxysmal Nocturnal Hemoglobinuria-Type Erythrocytes.
    Sugimoto T; Masui E; Ohata S; Goto H; Tomita T; Hashimoto H; Bouike Y
    Am J Case Rep; 2021 Nov; 22():e933102. PubMed ID: 34819489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demonstration of the deposition of hemosiderin in the kidneys of patients with paroxysmal nocturnal hemoglobinuria by magnetic resonance imaging.
    Suzukawa K; Ninomiya H; Mitsuhashi S; Anno I; Nagasawa T; Abe T
    Intern Med; 1993 Sep; 32(9):686-90. PubMed ID: 8142671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of complement activation in thrombosis and hemolytic anemias.
    Chapin J; Terry HS; Kleinert D; Laurence J
    Transfus Apher Sci; 2016 Apr; 54(2):191-8. PubMed ID: 27156108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune hemolytic anemia.
    Gehrs BC; Friedberg RC
    Am J Hematol; 2002 Apr; 69(4):258-71. PubMed ID: 11921020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival in autoimmune hemolytic anemia remains poor, results from a nationwide cohort with 37 years of follow-up.
    Hansen DL; Möller S; Frederiksen H
    Eur J Haematol; 2022 Jul; 109(1):10-20. PubMed ID: 35276014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement Activation and Inhibition in Autoimmune Hemolytic Anemia: Focus on Cold Agglutinin Disease.
    Berentsen S
    Semin Hematol; 2018 Jul; 55(3):141-149. PubMed ID: 30032751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A new approach for diagnosis of autoimmune hemolytic anemia].
    Kajii E; Omi T; Miura Y; Ikemoto S
    Rinsho Ketsueki; 1994 Apr; 35(4):336-40. PubMed ID: 8028177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathogenesis of erythrocyte destruction in autoimmune hemolytic anemia].
    Yatomi Y
    Nihon Rinsho; 1996 Sep; 54(9):2397-401. PubMed ID: 8890568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An observational analysis of disease burden in patients with cold agglutinin disease: Results from a large US electronic health record database.
    Pham HP; Wilson A; Adeyemi A; Miles G; Kuang K; Carita P; Joly F
    J Manag Care Spec Pharm; 2022 Dec; 28(12):1419-1428. PubMed ID: 36427340
    [No Abstract]   [Full Text] [Related]  

  • 17. [Autoimmune hemolytic anemia].
    Karasawa M
    Nihon Rinsho; 2008 Mar; 66(3):520-3. PubMed ID: 18326320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmune Hemolytic Anemia in the Pediatric Setting.
    Voulgaridou A; Kalfa TA
    J Clin Med; 2021 Jan; 10(2):. PubMed ID: 33435309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune hemolytic anemia: current knowledge and perspectives.
    Michalak SS; Olewicz-Gawlik A; Rupa-Matysek J; Wolny-Rokicka E; Nowakowska E; Gil L
    Immun Ageing; 2020 Nov; 17(1):38. PubMed ID: 33292368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New Insights in the Pathogenesis and Therapy of Cold Agglutinin-Mediated Autoimmune Hemolytic Anemia.
    Berentsen S
    Front Immunol; 2020; 11():590. PubMed ID: 32318071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.